NYSE:DGX Quest Diagnostics (DGX) Stock Price, News & Analysis $178.48 -1.28 (-0.71%) As of 12:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Quest Diagnostics Stock (NYSE:DGX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Quest Diagnostics alerts:Sign Up Key Stats Today's Range$178.13▼$179.7150-Day Range$166.38▼$184.2352-Week Range$146.17▼$185.62Volume162,924 shsAverage Volume1.15 million shsMarket Capitalization$19.96 billionP/E Ratio21.37Dividend Yield1.79%Price Target$186.00Consensus RatingModerate Buy Company Overview Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Read More Quest Diagnostics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks95th Percentile Overall ScoreDGX MarketRank™: Quest Diagnostics scored higher than 95% of companies evaluated by MarketBeat, and ranked 67th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingModerate Buy Consensus RatingQuest Diagnostics has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 7 buy ratings, 10 hold ratings, and no sell ratings.Amount of Analyst CoverageQuest Diagnostics has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Quest Diagnostics' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.14% Earnings GrowthEarnings for Quest Diagnostics are expected to grow by 8.14% in the coming year, from $9.70 to $10.49 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Quest Diagnostics is 21.39, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.52.Price to Earnings Ratio vs. SectorThe P/E ratio of Quest Diagnostics is 21.39, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 30.80.Price to Earnings Growth RatioQuest Diagnostics has a PEG Ratio of 2.39. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioQuest Diagnostics has a P/B Ratio of 2.75. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Quest Diagnostics' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.26% of the float of Quest Diagnostics has been sold short.Short Interest Ratio / Days to CoverQuest Diagnostics has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in Quest Diagnostics has recently increased by 3.49%, indicating that investor sentiment is decreasing. Dividend4.2 / 5Dividend StrengthStrong Dividend YieldQuest Diagnostics pays a meaningful dividend of 1.77%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthQuest Diagnostics has been increasing its dividend for 14 years.Dividend CoverageThe dividend payout ratio of Quest Diagnostics is 38.32%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Quest Diagnostics will have a dividend payout ratio of 30.51% next year. This indicates that Quest Diagnostics will be able to sustain or increase its dividend.Read more about Quest Diagnostics' dividend. Sustainability and ESG4.7 / 5Environmental Score-0.62 Percentage of Shares Shorted4.26% of the float of Quest Diagnostics has been sold short.Short Interest Ratio / Days to CoverQuest Diagnostics has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in Quest Diagnostics has recently increased by 3.49%, indicating that investor sentiment is decreasing. News and Social Media2.2 / 5News Sentiment0.98 News SentimentQuest Diagnostics has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 45 news articles for Quest Diagnostics this week, compared to 22 articles on an average week.Search InterestOnly 2 people have searched for DGX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Quest Diagnostics to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Quest Diagnostics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,278,787.00 in company stock.Percentage Held by InsidersOnly 8.16% of the stock of Quest Diagnostics is held by insiders.Percentage Held by Institutions88.06% of the stock of Quest Diagnostics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Quest Diagnostics' insider trading history. Receive DGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quest Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DGX Stock News HeadlinesQuest Diagnostics (NYSE:DGX) SVP Patrick Plewman Sells 4,532 SharesAugust 22, 2025 | insidertrades.comPatrick Plewman Sells 1,975 Shares of Quest Diagnostics (NYSE:DGX) StockAugust 20, 2025 | insidertrades.comA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.August 28 at 2:00 AM | Investors Alley (Ad)Quest Diagnostics Incorporated (NYSE:DGX) SVP Patrick Plewman Sells 5,535 SharesAugust 9, 2025 | insidertrades.comQuest Diagnostics Incorporated (NYSE:DGX) SVP Sells $375,700.00 in StockAugust 2, 2025 | insidertrades.comQuest Diagnostics’ Strategic Expansion with Corewell Health Drives Buy RatingAugust 28 at 3:11 AM | tipranks.comQuest Diagnostics (NYSE:DGX) Cut to Hold at Baird R WAugust 28 at 2:21 AM | americanbankingnews.comAre Wall Street Analysts Predicting Quest Diagnostics Stock Will Climb or Sink?August 27 at 5:11 PM | finance.yahoo.comSee More Headlines DGX Stock Analysis - Frequently Asked Questions How have DGX shares performed this year? Quest Diagnostics' stock was trading at $150.86 at the start of the year. Since then, DGX stock has increased by 18.3% and is now trading at $178.5320. How were Quest Diagnostics' earnings last quarter? Quest Diagnostics Incorporated (NYSE:DGX) issued its quarterly earnings results on Tuesday, July, 22nd. The medical research company reported $2.62 earnings per share for the quarter, beating analysts' consensus estimates of $2.57 by $0.05. Quest Diagnostics's revenue for the quarter was up 15.2% on a year-over-year basis. Read the conference call transcript. Does Quest Diagnostics have any subsidiaries? Quest Diagnostics subsidiaries include MACL, Blueprint Genetics, PhenoPath Laboratories, ReproSource, California Laboratory Associates, Cleveland HeartLab, Cape Cod Healthcare - Business, and others. When did Quest Diagnostics IPO? Quest Diagnostics (DGX) raised $12 million in an initial public offering on Tuesday, January 7th 2025. The company issued 2,300,000 shares at a price of $4.00-$6.00 per share. Dominari Securities and Revere Securities acted as the underwriters for the IPO. Who are Quest Diagnostics' major shareholders? Top institutional shareholders of Quest Diagnostics include Vanguard Group Inc. (12.73%), State Street Corp (4.64%), Boston Partners (2.72%) and Boston Partners (2.71%). Insiders that own company stock include J E Davis, Catherine T Doherty, Michael E Prevoznik, Michael J Deppe, Timothy M Ring, Vicky B Gregg, Patrick Plewman, Karthik Kuppusamy and Mark E Delaney. View institutional ownership trends. How do I buy shares of Quest Diagnostics? Shares of DGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Quest Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Quest Diagnostics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Adobe (ADBE), GE Aerospace (GE) and ServiceNow (NOW). Company Calendar Record date for 7/21 Dividend7/07/2025Ex-Dividend for 7/21 Dividend7/07/2025Dividend Payable7/21/2025Last Earnings7/22/2025Today8/28/2025Record date for 10/20 Dividend10/03/2025Ex-Dividend for 10/20 Dividend10/03/2025Dividend Payable10/20/2025Next Earnings (Estimated)10/28/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryHealth Care Services Current SymbolNYSE:DGX CIK1022079 Webwww.questdiagnostics.com Phone(973) 520-2700Fax201-462-4169Employees56,000Year Founded1967Price Target and Rating Average Price Target for Quest Diagnostics$186.00 High Price Target$200.00 Low Price Target$172.00 Potential Upside/Downside+3.5%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage18 Analysts Profitability EPS (Trailing Twelve Months)$8.35 Trailing P/E Ratio21.52 Forward P/E Ratio18.52 P/E Growth2.39Net Income$871 million Net Margins9.01% Pretax Margin11.93% Return on Equity15.24% Return on Assets6.64% Debt Debt-to-Equity Ratio0.71 Current Ratio1.09 Quick Ratio0.99 Sales & Book Value Annual Sales$9.87 billion Price / Sales2.04 Cash Flow$13.45 per share Price / Cash Flow13.36 Book Value$64.97 per share Price / Book2.77Miscellaneous Outstanding Shares111,820,000Free Float102,698,000Market Cap$20.09 billion OptionableOptionable Beta0.46 Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NYSE:DGX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredChase, Bank of America, Wells Fargo Preparing for BIG ChangeThanks to this brand-new law #S.1582 signed by President Trump… Jeff Brown believes the largest banks in Am...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest Diagnostics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.